Indication

Symptomatic congenital syphilis

Symptomatic congenital syphilis is an active, multisystem infectious disease in neonates and infants resulting from transplacental transmission of the spirochete *Treponema pallidum* from an untreated or inadequately treated mother. Read more about Symptomatic congenital syphilis

19 drugs 14 manufacturers

Advertisement

Drugs that treat it

Common Symptomatic congenital syphilis therapies.

Showing 19–19 of 19 drugs

Filter & compare in the drug finder →Opens the drug finder with Symptomatic congenital syphilis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Symptomatic congenital syphilis.

Symptomatic congenital syphilis is an active, multisystem infectious disease in neonates and infants resulting from transplacental transmission of the spirochete *Treponema pallidum* from an untreated or inadequately treated mother.

It affects multiple organ systems, most notably the reticuloendothelial, dermatologic, skeletal, hematologic, and central nervous systems.

Defining clinical features in early presentation include copious mucopurulent or bloody nasal discharge, maculopapular or vesicular desquamating skin rashes, hepatosplenomegaly, and cholestatic jaundice.

It is further characterized pathologically by osseous inflammation, such as osteochondritis and periostitis causing pseudoparalysis, alongside nonimmune hydrops fetalis, generalized lymphadenopathy, anemia, and central nervous system involvement.

Personalize your experience

Follow Symptomatic congenital syphilis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it